T.05.3 BASELINE ANXIETY SCORES PREDICT ESCALATION TO HIGHER DOSES OF PAROXETINE IN PATIENTS WITH FUNCTIONAL HEARTBURN AND REFLUX HYPERSENSITIVITY. (March 2023)